Company: CERO
Filing Date: 2025-10-16
Form Type: 8-K
Source: 0001213900-25-099560
Chunk: 3

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-10-16
Form: 8-K
Item: Item 9.01
Chunk 3
---
Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

The following exhibits are being filed herewith:

  Exhibit No.      Document                                                                                                                                                                                              
  3.1†             Certificate of Designation of Preferences, Rights and Limitations of the Series E Convertible Preferred Stock, dated October 14, 2025.                                                                
  10.1*†           Securities Purchase Agreement, dated as of October 14, 2025, by and between CERo Therapeutics Holdings, Inc. and the investors signatory thereto (incorporated by reference to Exhibit 10.1 of th...  
  104              Cover Page Interactive Data File (embedded within the Inline XBRL document).                                                                                                                          

  Schedules and exhibits have been omitted pursuant to Item 601(a)(5) of Regulation S-K. A copy of any omitted schedule and/or exhibit will be furnished to the SEC upon request.  

  Certain portions of this document that constitute confidential information have been redacted pursuant to Item 601(b)(10) of Regulation S-K.  

SIGNATURE

Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.

  Dated: October 16, 2025      CERO THERAPEUTICS HOLDINGS, INC.                               
 ──────────────────────────────────────────────────────────────────────────────────────────────
                               By:                                   /s/ Chris Ehrlich        
                               Name:                                 Chris Ehrlich            
                               Title:                                Chief Executive Officer